Investor
Lunate Capital Ltd
CIK 0002056786 · filed 2026-04-16 · SEC filing
13F book
$120.4M
Positions
6
Largest name
44.4%
Revolution Medicines Inc
Est. mark
−$12.7M
Price effect on 6 names still held. Flow −$131.2M.
| Name | Ticker | Shares | Value | Weight | Est. mark | Change |
|---|---|---|---|---|---|---|
| Revolution Medicines Inc | — | 549K | $53.4M | 44.4% | $9.66M | Cut−$121.5M |
| SailPoint, Inc. | SAIL | 3M | $39.7M | 33.0% | −$21M | Held |
| Lineage, Inc. | LINE | 600K | $19.7M | 16.3% | −$1.34M | Held |
| Neumora Therapeutics, Inc. | NMRA | 2.12M | $4.14M | 3.4% | $339.9K | Held |
| Navan, Inc. | NAVN | 200K | $2.65M | 2.2% | −$768K | Held |
| Revolution Medicines Inc | — | 450K | $805.5K | 0.7% | $382.5K | Held |
Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.